N-Q 1 world23complete.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF
REGISTERED MANAGEMENT COMPANY


Investment Company Act file number: 811-1027

Name of Registrant: Vanguard World Funds

Address of Registrant: P.O. Box 2600
Valley Forge, PA 19482

Name and address of agent for service: R. Gregory Barton, Esquire
P.O. Box 876
Valley Forge, PA 19482

Registrant’s telephone number, including area code: (610) 669-1000


Date of fiscal year end: August 31

Date of reporting period: May 31, 2005

Item 1: Schedule of Investments


Vanguard U.S. Growth Fund
Schedule of Investments
May 31, 2005
 
 
 
Shares

Market
Value
($000)

COMMON STOCK (97.3%)

   Auto & Transportation (0.4%)    
  Harley-Davidson, Inc. 533,200  $26,143 

   
   Consumer Discretionary (13.5%)
* Yahoo! Inc. 4,531,800  168,583 
* eBay Inc. 3,938,400  149,699 
* Google Inc. 401,550  111,791 
  Lowe's Cos., Inc. 1,659,233  94,925 
* Bed Bath & Beyond, Inc. 2,152,055  87,481 
  Avon Products, Inc. 1,502,585  59,713 
* Kohl's Corp. 1,128,159  54,930 
* Apollo Group, Inc. Class A 379,480  29,789 
  Wal-Mart Stores, Inc. 420,750  19,872 
* Starbucks Corp. 291,000  15,932 

       792,715 

   
   Consumer Staples (2.3%)
  Walgreen Co. 1,472,060  66,743 
  PepsiCo, Inc. 853,340  48,009 
  The Procter & Gamble Co. 351,800  19,402 

       134,154 

   
   Financial Services (14.1%)
  Legg Mason Inc. 2,171,300  178,437 
  Citigroup, Inc. 3,063,000  144,298 
  The Goldman Sachs Group, Inc. 1,393,840  135,899 
  American International Group, Inc. 1,913,400  106,289 
  First Data Corp. 1,751,600  66,263 
  Merrill Lynch & Co., Inc. 947,108  51,390 
  Charles Schwab Corp. 3,561,000  40,382 
  Paychex, Inc. 1,291,236  37,291 
  SLM Corp. 708,329  34,191 
  JPMorgan Chase & Co. 946,400  33,834 

       828,274 

   
   Health Care (27.8%)
* Zimmer Holdings, Inc. 2,374,470  181,837 
  UnitedHealth Group Inc. 3,655,486  177,584 
* Alcon, Inc. 1,579,945  161,581 
* WellPoint Inc. 1,157,936  154,005 
* Amgen, Inc. 2,119,995  132,669 
  Teva Pharmaceutical Industries Ltd. Sponsored ADR 3,671,000  122,501 
* St. Jude Medical, Inc. 2,808,500  112,677 
  Stryker Corp. 1,992,100  96,916 
  Medtronic, Inc. 1,671,376  89,836 
* Caremark Rx, Inc. 1,836,070  81,999 
* Forest Laboratories, Inc. 2,056,975  79,358 
* Genentech, Inc. 991,900  78,608 
  Sanofi-Synthelabo SA ADR 979,190  44,064 
  Pfizer Inc. 1,433,965  40,008 
  Eli Lilly & Co. 607,275  35,404 
  Allergan, Inc. 437,895  33,854 
* Boston Scientific Corp. 439,080  11,895 

       1,634,796 

   
   Integrated Oils (0.4%)
  Suncor Energy, Inc. 577,175  22,735 

   
   Other Energy (2.1%)
  Schlumberger Ltd. 1,393,730  95,289 
  Baker Hughes, Inc. 621,300  28,698 

       123,987 

   
   Materials & Processing (0.9%)
  Praxair, Inc. 1,125,060  52,732 

   
   Producer Durables (6.0%)
  Danaher Corp. 3,046,291  167,942 
  Centex Corp. 1,185,300  77,613 
  Lennar Corp. Class A 1,133,500  65,754 
  D. R. Horton, Inc. 1,165,033  40,275 

       351,584 

   
   Technology (26.5%)
* Dell Inc. 6,463,950  257,847 
* Marvell Technology Group Ltd. 4,322,800  177,062 
* Juniper Networks, Inc. 6,543,700  167,780 
* Symantec Corp. 5,772,700  130,521 
* Broadcom Corp. 3,499,800  124,208 
* EMC Corp. 7,852,810  110,411 
  QUALCOMM Inc. 2,415,600  90,005 
  SAP AG ADR 1,688,000  69,630 
  Taiwan Semiconductor Manufacturing Co. Ltd. ADR 6,351,475  58,497 
* Apple Computer, Inc. 1,432,800  56,896 
  Linear Technology Corp. 1,485,596  55,665 
* Accenture Ltd. 2,363,275  55,017 
* Network Appliance, Inc. 1,445,000  41,558 
* Corning, Inc. 2,627,100  41,193 
  Intel Corp. 1,507,660  40,601 
  Microsoft Corp. 1,556,689  40,163 
  Adobe Systems, Inc. 907,700  30,009 
  Infosys Technologies Ltd. ADR 167,900  12,146 

       1,559,209 

   
   Utilities (0.8%)
* Comcast Corp. Special Class A 1,581,095  50,026 

   
   Other (2.5%)
  General Electric Co. 2,562,090  93,465 
  3M Co. 732,670  56,159 

   
       149,624 

   

  TOTAL COMMON STOCKS
   (Cost $5,077,457)    5,725,979  

   TEMPORARY INVESTMENTS (3.1%)

   Exchange-Traded Fund (0.0%)
  Vanguard Index Participation Equity Receipts - Growth 3,100  158 

   Money Market Fund (2.7%)
  Vanguard Market Liquidity Fund, 3.018%** 157,162,404  157,162 

   
    Face    
    Amount    
    ($000)    

   U.S. Agency Obligation (0.4%)
  Federal National Mortgage Assn.†
   (1) 3.021%, 7/20/2005 $25,000  24,894 


TOTAL TEMPORARY INVESTMENTS
 (Cost $182,216)    182,214  

TOTAL INVESTMENTS (100.4%)
 (Cost $5,259,673)    5,908,193  

OTHER ASSETS AND LIABILITIES-NET (-0.4%)    (25,318)

NET ASSETS (100%)    $5,882,875 

*Non-income-producing security. **Money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
†The issuer operates under a congressional charter; its securities are neither issued nor guaranteed by the U.S. government. If needed, access to additional funding from the U.S. Treasury (beyond the issuer’s line of credit) would require congressional action.
(1)Securities with a value of $24,894,000 have been segregated as initial margin for open futures contracts.
ADR — American Depositary Receipt.

Investment Securities: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4:00 p.m. Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been materially affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued by methods deemed by the board of trustees to represent fair value. Investments in Vanguard Market Liquidity Fund are valued at that fund’s net asset value. Temporary cash investments acquired over 60 days to maturity are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services. Other temporary cash investments are valued at amortized cost, which approximates market value.

At May 31, 2005, the cost of investment securities for tax purposes was $5,259,673,000. Net unrealized appreciation of investment securities for tax purposes was $648,520,000, consisting of unrealized gains of $887,114,000 on securities that had risen in value since their purchase and $238,594,000 in unrealized losses on securities that had fallen in value since their purchase.

Futures Contracts: The fund invests a portion of its cash reserves in equity markets through the use of index futures contracts and exchange-traded funds. After giving effect to these investments, the fund’s effective common stock and temporary cash investment positions represent 99.6% and 0.8%, respectively, of net assets. Futures contracts are valued at their quoted daily settlement prices.

At May 31, 2005, the aggregate settlement value of open futures contracts expiring in June 2005, and the related unrealized appreciation (depreciation) were:


 
             (000)
 
 
Futures Contracts
Number
of
Long Contracts
Aggregate
Settlement
Value
Unrealized
Appreciation
(Depreciation)

Nasdaq 100 E-mini Index 4,060  $125,454  $7,921 

Nasdaq 100 Index 20  3,090  71 

S&P 500 E-mini Index 50  2,981  12 


Unrealized appreciation (depreciation) on open futures contracts is required to be treated as realized gain (loss) for tax purposes.


Item 2: Controls and Procedures.

(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

(b) Internal Control Over Financial Reporting. During the last fiscal quarter, there was no significant change in the Registrant’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3:

Exhibits.
(a) Certifications.

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VANGUARD WORLD FUNDS

BY: (signature)
(HEIDI STAM)
JOHN J. BRENNAN*
CHIEF EXECUTIVE OFFICER

Date: July 14, 2005

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

VANGUARD WORLD FUNDS

BY: (signature)
(HEIDI STAM)
JOHN J. BRENNAN*
CHIEF EXECUTIVE OFFICER

Date: July 14, 2005

VANGUARD WORLD FUNDS

BY: (signature)
(HEIDI STAM)
THOMAS J. HIGGINS*
TREASURER

Date: July 14, 2005

*By Power of Attorney. Filed on December 20, 2004, see File Number 002-14336. Incorporated by Reference.